12月25日，宝胜股份收涨1.93%，收盘价为6.88元，发生1笔大宗交易，合计成交量410.14万股，成交金 额2797.15万元。 第1笔成交价格为6.82元，成交410.14万股，成交金额2,797.15万元，溢价率为-0.87%，买方营业部为中 信建投证券股份有限公司总部，卖方营业部为东兴证券股份有限公司上海分公司。 进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为4334.85万元。该股近5个交易日累 计上涨7.67%，主力资金合计净流入8755.32万元。 责任编辑：小浪快报 ...

Core Insights - The announcements highlight various corporate activities including project investments, contract wins, equity acquisitions, share buybacks, and shareholding adjustments across multiple companies in different sectors. Project Investments - Haibo Technology plans to invest 2 billion yuan in the "Haibo Intelligent Green Energy Storage Factory Project" [1] Contract Wins - Baosheng Co., Ltd. has won a contract worth approximately 1.2 billion yuan from the Singapore Power Authority for power cable projects [1] - Qianjiang Water Conservancy has secured a contract for the integrated water supply and drainage project in Qimen County, Huangshan City [1] - Ningbo Construction has won a construction contract worth 428 million yuan as part of a consortium [1] Equity Acquisitions - Shanghai Jianlong intends to acquire a 40% stake in Hanxing Energy for 200 million yuan [1] - Ningbo Port plans to acquire 100% equity of the Comprehensive Bonded Zone Terminal for 706 million yuan to enhance its competitive edge [1] - Jinko Environment aims to acquire 100% equity of Eric for 84.8 million yuan [1] Share Buybacks - Weimais plans to repurchase shares with an investment of 50 million to 100 million yuan [1] Shareholding Adjustments - Yuan Meihe, a shareholder of Oke Yi, plans to reduce his stake by up to 1.89% [2] - Biological Holdings intends to increase its stake by investing between 50 million to 100 million yuan [2] - Chang'an Trust and Zhongbao Investment No. 1 Trust plan to reduce their holdings in Unisplendour by no more than 1% [1]

Group 1 - Rhine Biotech plans to change control by acquiring 80% stake in Beijing Jinkangpu, with the current controlling shareholder transferring 60 million shares (8.09% of total shares) and relinquishing voting rights on 189 million shares (25.5% of total shares) [1][2] - The acquisition is expected to be completed after the transfer of shares and the board of directors' restructuring, making Guangzhou Defu Nutrition the new controlling shareholder [1] - The specific transaction price for the acquisition of Beijing Jinkangpu is yet to be determined, and the transaction is not expected to constitute a major asset restructuring [2] Group 2 - Shida Shenghua and Bertli are planning to list H-shares on the Hong Kong Stock Exchange, with both companies considering the interests of existing shareholders and market conditions [3] - The listing process for both companies is in discussion with relevant intermediaries, and specific details have not yet been finalized [3] Group 3 - Ningbo Huaxiang's subsidiary has signed a contract for the production of robot joints, which is expected to positively impact future operating performance starting from January 2026 [4] Group 4 - Ningbo Port plans to acquire 100% of the equity of Zhoushan Port Comprehensive Bonded Zone Terminal for 706 million yuan to resolve competition issues [7] - The company aims to enhance its operational capabilities through this acquisition [7] Group 5 - Huaxin Building Materials' major shareholder plans to increase its stake in the company by 200 to 400 million yuan within six months [12] - The shareholder has secured a loan commitment of up to 360 million yuan from a bank to facilitate this purchase [12]

Group 1 - The company, Baoshen Technology Innovation Co., Ltd., has recently won a bid for a power cable project from the Singapore Power Authority, with a contract value of approximately 1.2 billion RMB (including tax) [2]

Group 1 - Shareholder of Okoyi plans to reduce holdings by up to 1.89% of the company's shares, amounting to a maximum of 3 million shares due to personal funding needs [1] - Tianchuang Fashion is planning a change in control, leading to continued suspension of its stock trading, expected to last no more than 3 trading days [2] - China Electric Power Construction Company reported a new contract amount of 10,317.55 billion yuan for the first 11 months of 2025, a year-on-year decrease of 1.65% [3] Group 2 - Pilin Bio's wholly-owned subsidiary received approval for a clinical trial of a drug, indicating progress in its product development [4] - Yihong Medical obtained two medical device registration certificates for diagnostic kits, enhancing its product portfolio [5] - Aohong Electronics plans to use up to 450 million yuan of idle fundraising for cash management, targeting safe and liquid financial products [6] Group 3 - China Electric Power Construction signed a contract worth approximately 6.626 billion yuan for a natural gas booster station project in Turkey, with a construction period of about 55 months [7] - Baosheng Co. won a bid for a power cable project in Singapore, valued at around 1.2 billion yuan, marking the largest overseas order in its history [8] - *ST Xinyan's stock will resume trading on December 24, 2025, following a capital increase plan that will raise its total share capital to 3.29 billion shares [9] Group 4 - Ningbo Construction's subsidiary signed a construction contract worth 428 million yuan for an engineering project with a duration of 990 days [11] - Lianhuan Pharmaceutical's subsidiary received approval for a drug that passed the consistency evaluation for generic drugs, enhancing its market competitiveness [12] - Zhongjie Automotive received a project designation for a new electric air conditioning compressor, with expected sales of approximately 29.86 million USD over its lifecycle [13] Group 5 - Biopharmaceuticals' major shareholder plans to increase holdings by 50 million to 100 million yuan, indicating confidence in the company's future [14] - Haizheng Pharmaceutical's subsidiary received approval for a veterinary drug product, expanding its product offerings in the animal health sector [15] - *ST Songfa's subsidiary signed contracts for the construction of 8 vessels, with a total contract value between 200 million to 400 million USD [16] Group 6 - Shandong Pharmaceutical Glass announced the resignation of its chairman due to age reasons, indicating a potential leadership transition [17] - Xinno Wei's subsidiary received approval for a clinical trial of a monoclonal antibody drug, indicating advancements in its drug development pipeline [18] - Ningbo Huaxiang's subsidiary secured an order for robot joints, expected to positively impact future business performance [19][20] Group 7 - China Resources Double Crane's subsidiary received approval for a clinical trial of a drug aimed at treating a genetic eye disease, reflecting ongoing R&D efforts [21] - Huaxin Technology's shareholders set a transfer price of 56.69 yuan per share for a block of shares, indicating active shareholder engagement [22] - Xinhua Net announced the resignation of its president due to job relocation, suggesting potential changes in management [23] Group 8 - Taiji Group plans to transfer a 40% stake in a subsidiary to focus on its core pharmaceutical business, enhancing operational efficiency [24] - Huaxin Construction's shareholder plans to increase holdings by 200 million to 400 million yuan, reflecting confidence in the company's prospects [25] - Dongjie Intelligent is planning to issue shares and cash for asset acquisition, with stock trading suspended until further notice [26] Group 9 - Wanrun New Energy was designated as a delivery warehouse for lithium carbonate futures, indicating its strategic position in the market [27] - Prolo Pharmaceutical's subsidiary received a drug registration certificate for an influenza treatment, expanding its product range [28] - Saiwu Technology invested 5 million yuan in a private equity fund focused on smart vehicles and energy innovation, indicating strategic investment in growth sectors [29] Group 10 - Bohui Innovation's subsidiary received approval for a clinical trial of an immunoglobulin drug, indicating progress in its product development [30] - Bohui Innovation's subsidiary also received a drug registration certificate for a coagulation factor product, enhancing its therapeutic offerings [31] - Hanghua Co. plans to allocate 146 million yuan of surplus fundraising for a new green printing materials project, reflecting a commitment to sustainability [32] Group 11 - Nova Star Cloud obtained a loan commitment letter from a bank for a share repurchase plan, indicating financial support for its capital management strategy [33] - Jimin Health established a joint venture for technology innovation, indicating a strategic move to enhance its technological capabilities [34] - Huili Pharmaceutical received a drug registration certificate for a medication used in treating digestive ulcers, expanding its product portfolio [35]

Core Viewpoint - The company has won a significant overseas contract with the Singapore Power Authority for power cable products, amounting to approximately 1.2 billion RMB (including tax), marking the largest single overseas order since its establishment [1] Group 1 - The contract won by the company is for power cable products [1] - The order value of approximately 1.2 billion RMB is the largest single overseas order in the company's history [1] - The fulfillment of this contract is expected to have a positive impact on the company's operating performance [1]

Core Viewpoint - The company, Baosheng Co., Ltd. (600973.SH), has recently won a bid for a power cable project from the Singapore Power Authority, with a contract value of approximately 1.2 billion RMB (including tax) [1] Group 1 - The project involves power cables, which are a key product category for the company [1] - This order represents the largest single overseas contract in the company's history since its establishment [1] - The formal execution of the contract is expected to have a positive impact on the company's operational performance [1]

宝胜股份12月23日公告，近日已中标新加坡电力局电力电缆项目，中标金额约12亿元（含税）。公司本 次中标的产品类别属于电力电缆，该笔订单是公司成立以来单笔中标金额最大的海外订单，待正式合同 履约后将对公司的经营业绩产生积极影响。 ...

转自：证券时报 人民财讯12月23日电，宝胜股份(600973)12月23日公告，公司近日已中标新加坡电力局电力电缆项目， 中标金额约12亿元（人民币，含税）。该笔订单是公司成立以来单笔中标金额最大的海外订单。 ...

Core Viewpoint - The company has recently won a bid for a power cable project from the Singapore Power Authority, with a contract value of approximately 1.2 billion RMB (including tax) [1] Group 1: Company Developments - The company has accelerated its overseas market expansion, actively exploring markets in Southeast Asia and the Middle East [1] - The direct export of the company's cable products has shown a year-on-year increase in recent years [1] - Winning this project marks a new milestone in the company's overseas market development, providing strong support for the stability of its future performance [1]